Short Interest in Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Increases By 153.3%

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the target of a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 46,045 shares, a growth of 153.3% from the May 14th total of 18,181 shares. Approximately 1.8% of the company’s shares are sold short. Based on an average daily trading volume, of 130,709 shares, the short-interest ratio is presently 0.4 days.

Catheter Precision Trading Down 1.9%

Shares of VTAK traded down $0.02 on Friday, hitting $1.05. 23,079 shares of the stock traded hands, compared to its average volume of 100,020. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $2.82 million, a P/E ratio of -0.08 and a beta of -1.01. The stock’s 50 day moving average is $0.94 and its two-hundred day moving average is $1.52. Catheter Precision has a 1 year low of $0.75 and a 1 year high of $8.50.

Catheter Precision (NYSEAMERICAN:VTAK) last announced its quarterly earnings data on Monday, May 18th. The company reported ($1.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($20.90) by $19.51. The business had revenue of $0.43 million for the quarter, compared to the consensus estimate of $1.60 million. Catheter Precision had a negative net margin of 1,297.56% and a negative return on equity of 76.51%.

Hedge Funds Weigh In On Catheter Precision

A hedge fund recently bought a new stake in Catheter Precision stock. Millennium Management LLC purchased a new position in shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 34,721 shares of the company’s stock, valued at approximately $64,000. Millennium Management LLC owned 2.08% of Catheter Precision as of its most recent SEC filing. Institutional investors own 20.34% of the company’s stock.

Catheter Precision Company Profile

Catheter Precision, Inc (NYSE American: VTAK) is a medical device company specializing in the design, development and manufacture of catheter-based products for interventional cardiology and peripheral vascular procedures. The company’s core business centers on balloon catheter platforms, offering both standard and specialty catheter configurations that address applications ranging from percutaneous transluminal angioplasty (PTA) to percutaneous transluminal coronary angioplasty (PTCA). Catheter Precision’s product portfolio is engineered to meet diverse clinical needs, including high-pressure dilation, scored and cutting balloon therapies, and drug-coated balloon delivery.

All of Catheter Precision’s products are developed in its ISO 13485-certified, FDA-registered manufacturing facility in Bloomington, Minnesota.